Scientific External Advisory Board
VCU Massey Cancer Center's Scientific External Advisory Board is composed of scientists and senior leaders from other major cancer centers. This distinguished committee of experts in cancer research, prevention and control and administration serves in an advisory capacity for Massey's director and senior leaders on matters of scientific program structure and research and overall Center planning and management. In addition to the standing external advisory membership, ad hoc advisors are added to the roster periodically to assess and advise regarding specific programs, shared resources or inter-programmatic activities.
Members
H. Shelton Earp, M.D., committee chair
director
Lineberger Comprehensive Cancer Center
University of North Carolina
Michael Becich, M.D., Ph.D.
director, pathology informatics
University of Pittsburgh Cancer Institute
Webster K. Cavenee, Ph.D.
director
Ludwig Institute for Cancer Research
University of California at San Diego
Theodore DeWeese, M.D.
chair, Department of Radiation Oncology & Molecular Radiation Sciences
Bloomberg School of Public Health
Johns Hopkins University
Mark Dewhirst, D.V.M., Ph.D.
director, Radiation Oncology Research Program
Duke Comprehensive Cancer Center
Duke University Medical Center
Robert Diasio, M.D.
director
Mayo Clinic Comprehensive Cancer Center
Peter Embi, M.D., M.S.
vice chair, Department of Biomedical Informatics
Ohio State University Medical Center
Beverly R. Ginsburg-Cooper, M.B.A.
senior vice president for research
Dana Farber Cancer Institute
Steven J. Katz, M.D., M.P.H.
professor, Departments of Medicine and Health Management & Policy
University of Michigan Comprehensive Cancer Center
KyungMann Kim, Ph.D.
professor, Department of Biostatistics & Medical Informatics
University of Wisconsin School of Medicine and Public Health
Edmund Lattime, Ph.D.
deputy director
Cancer Institute of New Jersey
Derek Raghavan, M.D., Ph.D.
president
Levine Cancer Institute
Carolinas HealthCare System
Frank J. Rauscher III, Ph.D.
deputy director, basic research
Wistar Institute
Ann G. Schwartz, Ph.D., M.P.H.
deputy director
Karmanos Cancer Institute
Wayne State University School of Medicine
Donald “Skip” Trump, M.D.
president & CEO
Roswell Park Cancer Institute
Daniel Welch, Ph.D.
chair, Department of Cancer Biology
University of Kansas Cancer Center
